> top > docs > PubMed:33008453 > annotations

PubMed:33008453 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 61-65 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T2 72-85 Body_part denotes lymphoblastic http://purl.org/sig/ont/fma/fma83030
T3 304-308 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T4 315-328 Body_part denotes lymphoblastic http://purl.org/sig/ont/fma/fma83030
T5 504-512 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T6 955-960 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T7 1097-1103 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T8 1549-1559 Body_part denotes lymphocyte http://purl.org/sig/ont/fma/fma62863
T9 1565-1573 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 955-960 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 7-15 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 59-94 Disease denotes B cell acute lymphoblastic leukemia http://purl.obolibrary.org/obo/MONDO_0004947|http://purl.obolibrary.org/obo/MONDO_0020511
T4 66-94 Disease denotes acute lymphoblastic leukemia http://purl.obolibrary.org/obo/MONDO_0004967
T5 72-94 Disease denotes lymphoblastic leukemia http://purl.obolibrary.org/obo/MONDO_0001018
T6 86-94 Disease denotes leukemia http://purl.obolibrary.org/obo/MONDO_0005059
T7 96-104 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T8 196-206 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T9 302-337 Disease denotes B cell acute lymphoblastic leukemia http://purl.obolibrary.org/obo/MONDO_0004947|http://purl.obolibrary.org/obo/MONDO_0020511
T11 309-337 Disease denotes acute lymphoblastic leukemia http://purl.obolibrary.org/obo/MONDO_0004967
T12 315-337 Disease denotes lymphoblastic leukemia http://purl.obolibrary.org/obo/MONDO_0001018
T13 329-337 Disease denotes leukemia http://purl.obolibrary.org/obo/MONDO_0005059
T14 465-473 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 585-593 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T16 664-672 Disease denotes leukemia http://purl.obolibrary.org/obo/MONDO_0005059
T17 749-757 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T18 836-844 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T19 845-854 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T20 860-871 Disease denotes lymphopenia http://purl.obolibrary.org/obo/MONDO_0003783
T21 1237-1245 Disease denotes leukemia http://purl.obolibrary.org/obo/MONDO_0005059
T22 1372-1380 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T23 1486-1494 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T24 1641-1649 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 16-21 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T2 59-65 http://purl.obolibrary.org/obo/CL_0000236 denotes B cell
T3 107-110 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T4 240-241 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 250-251 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 264-270 http://purl.obolibrary.org/obo/UBERON_0003100 denotes female
T7 302-308 http://purl.obolibrary.org/obo/CL_0000236 denotes B cell
T8 354-355 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 497-498 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T10 827-828 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T11 955-960 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T12 1097-1103 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T13 1116-1118 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T14 1399-1400 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 391-400 Chemical denotes rituximab http://purl.obolibrary.org/obo/CHEBI_64357
T2 402-412 Chemical denotes cytarabine http://purl.obolibrary.org/obo/CHEBI_28680
T3 418-427 Chemical denotes dasatinib http://purl.obolibrary.org/obo/CHEBI_49375|http://purl.obolibrary.org/obo/CHEBI_70839
T5 689-698 Chemical denotes rituximab http://purl.obolibrary.org/obo/CHEBI_64357
T6 700-710 Chemical denotes cytarabine http://purl.obolibrary.org/obo/CHEBI_28680
T7 716-725 Chemical denotes dasatinib http://purl.obolibrary.org/obo/CHEBI_49375|http://purl.obolibrary.org/obo/CHEBI_70839
T9 1053-1061 Chemical denotes steroids http://purl.obolibrary.org/obo/CHEBI_35341
T10 1133-1139 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-95 Sentence denotes Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia.
T2 96-223 Sentence denotes SARS-CoV-2 has infected millions of people worldwide, but little is known at this time about second infections or reactivation.
T3 224-428 Sentence denotes Here, we report a case of a 55-year-old female undergoing treatment for CD20+ B cell acute lymphoblastic leukemia who experienced a viral reactivation after receiving rituximab, cytarabine, and dasatinib.
T4 429-609 Sentence denotes She was initially hospitalized with COVID-19 in April and developed a high antibody titer with two negative nasal polymerase chain reaction (PCR) swabs for SARS-CoV-2 on discharge.
T5 610-726 Sentence denotes After recovery, she resumed treatment in June for her leukemia, which included rituximab, cytarabine, and dasatinib.
T6 727-812 Sentence denotes She promptly lost her COVID-19 antibodies, and her nasal PCR turned positive in June.
T7 813-1039 Sentence denotes She developed a severe COVID-19 pneumonia with lymphopenia, high inflammatory markers, and characteristic bilateral ground-glass opacities on chest CT, requiring high-flow nasal cannula and transfer to the intensive care unit.
T8 1040-1140 Sentence denotes She received steroids, anticoagulation, and convalescent plasma, and within 48 h she was off oxygen.
T9 1141-1204 Sentence denotes She was discharged home in stable condition several days later.
T10 1205-1422 Sentence denotes Given the short time frame from leukemia treatment to PCR positivity and the low case rate in mid-June in New York City, reinfection appears to have been unlikely and SARS-CoV-2 reactivation is a possible explanation.
T11 1423-1665 Sentence denotes This case illustrates the risks of treating recently recovered COVID-19 patients with immunosuppressive therapy, particularly lymphocyte- and antibody-depleting therapy, and raises new questions about the potential of SARS-CoV-2 reactivation.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 7-21 Species denotes COVID-19 virus Tax:2697049
3 72-94 Disease denotes lymphoblastic leukemia MESH:D054198
28 96-106 Species denotes SARS-CoV-2 Tax:2697049
29 132-138 Species denotes people Tax:9606
30 196-206 Disease denotes infections MESH:D007239
31 296-300 Gene denotes CD20 Gene:54474
32 315-337 Disease denotes lymphoblastic leukemia MESH:D054198
33 391-400 Chemical denotes rituximab MESH:D000069283
34 402-412 Chemical denotes cytarabine MESH:D003561
35 418-427 Chemical denotes dasatinib MESH:D000069439
36 465-473 Disease denotes COVID-19 MESH:C000657245
37 585-595 Species denotes SARS-CoV-2 Tax:2697049
38 664-672 Disease denotes leukemia MESH:D007938
39 689-698 Chemical denotes rituximab MESH:D000069283
40 700-710 Chemical denotes cytarabine MESH:D003561
41 716-725 Chemical denotes dasatinib MESH:D000069439
42 749-757 Disease denotes COVID-19 MESH:C000657245
43 836-854 Disease denotes COVID-19 pneumonia MESH:C000657245
44 860-871 Disease denotes lymphopenia MESH:D008231
45 1053-1061 Chemical denotes steroids MESH:D013256
46 1133-1139 Chemical denotes oxygen MESH:D010100
47 1237-1245 Disease denotes leukemia MESH:D007938
48 1372-1382 Species denotes SARS-CoV-2 Tax:2697049
49 1486-1494 Disease denotes COVID-19 MESH:C000657245
50 1495-1503 Species denotes patients Tax:9606
51 1641-1651 Species denotes SARS-CoV-2 Tax:2697049

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 66-94 Phenotype denotes acute lymphoblastic leukemia http://purl.obolibrary.org/obo/HP_0006721
T2 309-337 Phenotype denotes acute lymphoblastic leukemia http://purl.obolibrary.org/obo/HP_0006721
T3 664-672 Phenotype denotes leukemia http://purl.obolibrary.org/obo/HP_0001909
T4 845-854 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T5 860-871 Phenotype denotes lymphopenia http://purl.obolibrary.org/obo/HP_0001888
T6 1237-1245 Phenotype denotes leukemia http://purl.obolibrary.org/obo/HP_0001909

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-95 Sentence denotes Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia.
T2 96-223 Sentence denotes SARS-CoV-2 has infected millions of people worldwide, but little is known at this time about second infections or reactivation.
T3 224-428 Sentence denotes Here, we report a case of a 55-year-old female undergoing treatment for CD20+ B cell acute lymphoblastic leukemia who experienced a viral reactivation after receiving rituximab, cytarabine, and dasatinib.
T4 429-609 Sentence denotes She was initially hospitalized with COVID-19 in April and developed a high antibody titer with two negative nasal polymerase chain reaction (PCR) swabs for SARS-CoV-2 on discharge.
T5 610-726 Sentence denotes After recovery, she resumed treatment in June for her leukemia, which included rituximab, cytarabine, and dasatinib.
T6 727-812 Sentence denotes She promptly lost her COVID-19 antibodies, and her nasal PCR turned positive in June.
T7 813-1039 Sentence denotes She developed a severe COVID-19 pneumonia with lymphopenia, high inflammatory markers, and characteristic bilateral ground-glass opacities on chest CT, requiring high-flow nasal cannula and transfer to the intensive care unit.
T8 1040-1140 Sentence denotes She received steroids, anticoagulation, and convalescent plasma, and within 48 h she was off oxygen.
T9 1141-1204 Sentence denotes She was discharged home in stable condition several days later.
T10 1205-1422 Sentence denotes Given the short time frame from leukemia treatment to PCR positivity and the low case rate in mid-June in New York City, reinfection appears to have been unlikely and SARS-CoV-2 reactivation is a possible explanation.
T11 1423-1665 Sentence denotes This case illustrates the risks of treating recently recovered COVID-19 patients with immunosuppressive therapy, particularly lymphocyte- and antibody-depleting therapy, and raises new questions about the potential of SARS-CoV-2 reactivation.
T1 0-95 Sentence denotes Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia.
T2 96-223 Sentence denotes SARS-CoV-2 has infected millions of people worldwide, but little is known at this time about second infections or reactivation.
T3 224-428 Sentence denotes Here, we report a case of a 55-year-old female undergoing treatment for CD20+ B cell acute lymphoblastic leukemia who experienced a viral reactivation after receiving rituximab, cytarabine, and dasatinib.
T4 429-609 Sentence denotes She was initially hospitalized with COVID-19 in April and developed a high antibody titer with two negative nasal polymerase chain reaction (PCR) swabs for SARS-CoV-2 on discharge.
T5 610-726 Sentence denotes After recovery, she resumed treatment in June for her leukemia, which included rituximab, cytarabine, and dasatinib.
T6 727-812 Sentence denotes She promptly lost her COVID-19 antibodies, and her nasal PCR turned positive in June.
T7 813-1039 Sentence denotes She developed a severe COVID-19 pneumonia with lymphopenia, high inflammatory markers, and characteristic bilateral ground-glass opacities on chest CT, requiring high-flow nasal cannula and transfer to the intensive care unit.
T8 1040-1140 Sentence denotes She received steroids, anticoagulation, and convalescent plasma, and within 48 h she was off oxygen.
T9 1141-1204 Sentence denotes She was discharged home in stable condition several days later.
T10 1205-1422 Sentence denotes Given the short time frame from leukemia treatment to PCR positivity and the low case rate in mid-June in New York City, reinfection appears to have been unlikely and SARS-CoV-2 reactivation is a possible explanation.
T11 1423-1665 Sentence denotes This case illustrates the risks of treating recently recovered COVID-19 patients with immunosuppressive therapy, particularly lymphocyte- and antibody-depleting therapy, and raises new questions about the potential of SARS-CoV-2 reactivation.